GB2178447A - A matrix for cell cultivation in vitro - Google Patents
A matrix for cell cultivation in vitro Download PDFInfo
- Publication number
- GB2178447A GB2178447A GB08614799A GB8614799A GB2178447A GB 2178447 A GB2178447 A GB 2178447A GB 08614799 A GB08614799 A GB 08614799A GB 8614799 A GB8614799 A GB 8614799A GB 2178447 A GB2178447 A GB 2178447A
- Authority
- GB
- United Kingdom
- Prior art keywords
- matrix
- cells
- fibers
- cell
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000011159 matrix material Substances 0.000 title claims abstract description 99
- 238000000338 in vitro Methods 0.000 title claims description 16
- 238000004113 cell culture Methods 0.000 title claims description 14
- 239000000835 fiber Substances 0.000 claims abstract description 59
- 239000002245 particle Substances 0.000 claims abstract description 24
- 239000011148 porous material Substances 0.000 claims abstract description 17
- 239000000758 substrate Substances 0.000 claims abstract description 3
- 210000004027 cell Anatomy 0.000 claims description 156
- 239000002609 medium Substances 0.000 claims description 53
- 235000015097 nutrients Nutrition 0.000 claims description 30
- -1 polypropylene Polymers 0.000 claims description 22
- 230000010261 cell growth Effects 0.000 claims description 20
- 239000004743 Polypropylene Substances 0.000 claims description 16
- 239000007789 gas Substances 0.000 claims description 16
- 239000001963 growth medium Substances 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 16
- 229920001155 polypropylene Polymers 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 15
- 229920000728 polyester Polymers 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 229920000642 polymer Polymers 0.000 claims description 10
- 239000012530 fluid Substances 0.000 claims description 8
- 239000004745 nonwoven fabric Substances 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 7
- 239000000725 suspension Substances 0.000 claims description 7
- 239000002699 waste material Substances 0.000 claims description 6
- 239000012510 hollow fiber Substances 0.000 claims description 5
- 230000007935 neutral effect Effects 0.000 claims description 5
- 102000008186 Collagen Human genes 0.000 claims description 4
- 108010035532 Collagen Proteins 0.000 claims description 4
- 229920001436 collagen Polymers 0.000 claims description 4
- 230000005484 gravity Effects 0.000 claims description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 4
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 239000004793 Polystyrene Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 230000007423 decrease Effects 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 229920002223 polystyrene Polymers 0.000 claims description 3
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 claims description 2
- 230000000737 periodic effect Effects 0.000 claims description 2
- 229920002492 poly(sulfone) Polymers 0.000 claims description 2
- 239000004800 polyvinyl chloride Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 238000012606 in vitro cell culture Methods 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 238000012412 chemical coupling Methods 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 230000005495 cold plasma Effects 0.000 claims 1
- 239000007822 coupling agent Substances 0.000 claims 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims 1
- 239000002657 fibrous material Substances 0.000 claims 1
- 239000003365 glass fiber Substances 0.000 claims 1
- 150000008282 halocarbons Chemical class 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 229920001281 polyalkylene Polymers 0.000 claims 1
- 229920006254 polymer film Polymers 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 abstract description 11
- 239000006260 foam Substances 0.000 abstract 1
- 230000012010 growth Effects 0.000 description 23
- 239000002054 inoculum Substances 0.000 description 14
- 210000002966 serum Anatomy 0.000 description 13
- 238000004114 suspension culture Methods 0.000 description 13
- 239000011324 bead Substances 0.000 description 8
- 238000007654 immersion Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 125000006850 spacer group Chemical group 0.000 description 7
- 239000010410 layer Substances 0.000 description 6
- 239000011325 microbead Substances 0.000 description 6
- 239000000499 gel Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 238000003306 harvesting Methods 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 239000003094 microcapsule Substances 0.000 description 4
- 238000010899 nucleation Methods 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 230000010412 perfusion Effects 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 210000004408 hybridoma Anatomy 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 2
- 229920000297 Rayon Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000004873 anchoring Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 229920005594 polymer fiber Polymers 0.000 description 2
- 239000002964 rayon Substances 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229920002972 Acrylic fiber Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- HNNIWKQLJSNAEQ-UHFFFAOYSA-N Benzydamine hydrochloride Chemical compound Cl.C12=CC=CC=C2C(OCCCN(C)C)=NN1CC1=CC=CC=C1 HNNIWKQLJSNAEQ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000003490 calendering Methods 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 238000011072 cell harvest Methods 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000030944 contact inhibition Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000011152 fibreglass Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 244000144992 flock Species 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 229960000187 tissue plasminogen activator Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/10—Perfusion
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/14—Scaffolds; Matrices
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/32—Polylysine, polyornithine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Sustainable Development (AREA)
- Immunology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Nonwoven Fabrics (AREA)
Abstract
A matrix and cultivation system for anchorage dependent cells has a substantially increased available effective surface area for cell attachment provided by a fiber network or open-pore foams with suitable pore size of 10 mu to 100 mu . Attachment of the cells can be enhanced by modifying the surface of the substrate. One embodiment comprises a matrix in particle or flake form.
Description
SPECIFICATION
A matrix for cell cultivation in vitro
Field of the invention
The present invention relates to the in vitro cultivation and growth of various of living cells, and in particular to methods and devices for in vitro growth of mammalian tissue cells that require (in addition to sterile liquid nutrient media) attachment to a solid surface in order to effectively grow, metabolize nutrients, reproduce, and produce biologically active materials. Such tissue cells are called "anchorage dependent" cells. The provision of suitable surfaces to which such cells will attach themselves, is an essential requisite for their in vitro cultivation.
Background of the invention
Tissue cell culture is therefore carried out on solid continuous surfaces. On laboratory scale these are in the form of petri-dishes, flat sided bottle or roller bottles. Recent improvements, applicable also to large scale culture have been the development of spheres of various sizes such as microbeads, as well as of ceramic blocks traversed by small rectangular channels. In all these devices the cells adhere and propgate on the available surface of a solid.
Cells will attach only to surfaces that have suitable surface compositions and an electrical surface charge.
Materials that have proved successful for this purpose are glass, ceramics, polyvinyl chloride, polystyrene, dextran, collagen, and certain other materials. Frequently the cell attachment surfaces of such materials are treated with 95% sulfuric acid, or preferably with a corona or oxygen plasma discharge to improve cell adherence. Under culturing conditions such as those described in (Kruse & Patterson Tissue Culture - Methods and Applications, Academic Press 1983), cells coming in contact with these surfaces will attach themselves to the surface, and reproduce until they cover the surfaces in a contiguous, confluent monolayer. On reaching confluence cell growth ceases. The phenomenon of cell growth cessation when a contiguous layer of cells is achieved is called "contact inhibition" and is a characteristic of non-cancerous cell growth on two dimensional surfaces.
The growth surfaces used at present for in vitro tissue culture suffer from certain serious shortcomings:
a) They provide limited area per unit volume of nutrient medium supplied, so that the number of cells that can be grown per unit volume of nutrient medium is as much as three orders of magnitude smaller than the volumetric densities of cells in in vitro tissue.
b) They require high concentrations of inoculated cells in order to initiate cell growth. Typically cells are introduced to a fresh culture surface at a concentration and number which is 20-30% of the final number reached at confluence and it is usually impossible to inoculate with less then 10% of the number reached at confluence.
c) Cell growth of non-cancerous cells limited to monolayers;
d) Cells tend to detach from their anchorage surface under conditions that include: monolayer saturation; high or low serum concentration; medium depletion, and particularly, viscous shear caused by stirring or perfusion of the culture medium. Cell growth and biosynthesis stop on cell detachment.
Though non cancerous cells are grown on two dimenisonal surfaces, it has long been known that normal cells will also grow in gels, and specifically those of collagen. One such gel is available commerically (trade name "Gelfoam", Upjohn, Kalmazoo). Gels have however a poor dimensional stablility and, due to their internal structure are unsuitable for growing cells to a reasonable density and especially not for systems with medium perfusion. They have therefore not found use for the large scale culture of cells. Their use in limited to laboratory studies of cell morphology, or studies of the "hystotypic" growth of primary cultures (e.g. Dougles et al., In Vitro, 16, 306-312 (1980)).
Also relevant to this invention is the fact that certain cells and particularly cancerous mammalian cells and altered forms of cells such as hybridomas can be grown freely suspended in culture medium or immobilized in small beads of porous gelled material such as carrageenan, agarose, collagen, gelatin and similar starch or protein
or polymer materials. Cells may be mixed into such gels prior to casting the gels into the form of small beads or
particles that will be suspended in nutrient medium. (Karkare, S.B., Phillips, P.G., Burke, D.H., and Dean Jr., R.C.
"Continuous Production of Monoclonal Antibodies by Immobilized Hybridoma Culture" A.C.S. Annual Meeting
Phila. Pa, Aug 27, 1984, available from Verax Corp. Hanover, N.H.).
Alternatively, cells may be immobilized in microcapsules as described by Lim et al., Microencapsulation of
Living Cells and Tissues; J. Pharm. Sci., 70, 4: 351-354, April 1981; Nilsson., Entrapment of Animal Cells for
Production of Monoclonal Antibodies and other Biochemicals, Nature 302, 629-630, 1973.
The invention herein described also relates to the cultivation of such non-anchorage dependent cells and other
cells whose growth and harvesting may be facilitated by some form of immobilization as described above.
Summary of the invention
According to the present invention htere are provided:
A matrix for use in cell cultivation in vitro providing a high-surface-area substrate the effective area of which is from 10 to about 100 times the area of same projected onto a plane surface, comprising a physiologically
acceptable network of fibers having a porosity of from 40 to about 95% and a pores size of the order of 10 p to
100 p, or an open-pore foamed structure with a pore size of from about 10 p ot 100 p, the overall height of the
matrix being of the order of from 50 p to about 500 p;
A matrix where the 3-dimensional structure is one of a non-woven fabric from round, flat, non-round, or hollow fibers or combination of such fibers of the order of from 0.5 pm to 50 pm diameter or width;;
A matrix where the structure is composed of ribbon formed fibers of 2 um to 20 pm width which may be crimped, and where the ratio of width to thickness is 2:1 or more;
A matrix for anchorage dependent cell attachment that has a high surface density by which is meant a high specific surface area, or surface area per unit of projected surface or, high surface area per unit volume of surrounding medium;
A surface that increases the density of cells grown per unit volume of medium by at least one order of magnitude greater than that achievable in flat plate cultures;
A high specific surface cell attachment matrix that may be disposed as a flat sheet;
A matrix that may be disposed as a spiral sheet or as corrugated sheets.;
A matrix that may be disposed as suspended cell carrier in a stirred culture tank reactor;
A matrix that can be easily sampled for determining cells numbers;;
A matrix that can be easily samples for microscopic examination;
A matrix that protects cells from impact and viscous shear;
A matrix that inhibits detachment of cells from said surface;
A matrix that permits cell growth to be initiated at low inoculation densities, and consequently permits cell densities and number to increase by more than 10 fold, thus reducing the number of cultures that need to be started to achieve high production of cells and cell products;
A matrix that permits cell growth in multiple layers and in a three dimensional matrix;
A matrix that permits cells to grow in three dimensional non-planar forms;
A matrix that allows rapid inward diffusion of materials such as nutrients, hormones, growth factors and serum components and outward diffusion of metabolic wastes and cell products;;
A matrix for growing anchorage-dependent or non-anchorage dependent cells, said matrix providing high internal surface area and high internal volume with pores that are 1 to 20 times the volume of individual cells, said pores being within 100 micrometer of the exterior surface of the matrix so as to provide rapid diffusion throughout and into and out of the matrix;
A matrix for entrapping cells that are not anchorage-dependent, that facilitates the harvesting of such cells in suspension culture;
A matrix for protecting and growing non-anchorage dependent cells at high density while exposed to fluid nutrients that are moving at high velocities and that are under high shear;
A matrix for entrapping or anchoring cells that has a near neutral buoyancy so that particles made of this matrix may be suspended in nutrient medium with minimal amounts of stirring;;
A matrix for anchoring or entrapping cells that has a variable buoyancy controlled by the pressure imposed on the cell culture vessel, so as to permit moving the matrix up and down through the nutrient liquid by lowering or raising the pressure in the cell culture vessel;
A process for producing tissue plasminogen activator at high concentrations and in large volumes of culture, while conserving serum and preventing dilution of cell products in excess medium, and means for carrying our such process.
These and other objectives will became apparent from the following detailed disclosure.
General description of the invention
According to the invention there is provided a growth matrix that substantially increases the available attachment surface for the adherence of the cultivated cells: the increase is by a factor of from 10 to 30 times, calculated on the projection of the base on which structures of the invention are supported. Such an increase by a factor of 10 to 30 times, is per unit layer, and if a plurality of such layers, separated by spacers or the like, is used, the factor of 10 to 30 times applies per each such structure.When the matrix is used in sheet form, preferably non-woven fiber sheets, or sheets of open-pore framed polymers, the preferred thickness of the sheet is about 50 to 250 pom, there being provided adequate porosity for cell entrance, entrance of nutrients and for removal of waste products from the sheet said pores having an effective diameter of 10 pm to 100 vim. Such sheets can be be prepared from fibers of various thicknesses, the preferred fiber thickness or fiber diameter range being from 0.5 um to 20 pm, still more preferred being in the range of 10 pm to 15 pm diameter.
A plurality of such sheets can be used, stacked above each other, and in such case suitable spacing means are resorted to. A porous spacer of from 150 um to about a millimeter generally gives satisfactory results.
The structures of the invention may be supported by, or even better bonded to, a porous support sheet or screen providing for dimensional stability and physical strength.
Such matrix sheets may also be cut, punched, or shredded to provide particles with projected area of the order of about 0.2 mm2 to about 10 mm2, with the same order of thickness (about 50 to 250 pom), said particles being particularly useful in suspension of fluidized culture.
The present invention relates also to devices or matrices for entrapping and growing non-anchorage dependent cells in open encapsulation, providing a protected micro-environment for growth of cells and facilitating cell harvest.
To produce large quantities of non-anchorage dependent cells, the cells are usually grown in suspension in a nutrient liquid medium that is stirred to ensure that each cell is adequately bathed in nutrients, and that metabolic wastes are carried away from the cell. A certain fraction of the cells is destroyed by impact with the impeller or by high shear. Harvesting cells from conventional suspension culture requires special supplemental equipment such as centrifuges or micro-porous filters. Also cell concentration per cubic centimeter of nutrient liquid is relatively low.
One method of simplifying the harvesting of such cells and increasing their density involves encapsulating the cells in permeable microcapsules as described by the preciously cited works of Lim and Nilsson. These microcapsules are larger and denser than the cells they entrap. Consequently they are easily separated from the nutrient medium by settling or by filtration. The microcapsules have certain disadvantages:
- they are costly and delicate to produce;
- at high density growth, cells at the center of the capsule frequently die;
- capsules may burst prematurely losing their content cells.
- each new inoculation requires a fresh encapsulation procedure.
The present invention pertains to the provision of forms of materials that provide improved surfaces and morphologies for cell attachment and/or entrapment during in vitro culture, said improved surfaces and morphologies overcoming the shortcomings of currently used attachment surfaces, as well as providing new capabilities for improved culture of other cells not requiring an anchorage surface.
Porous sheets as cell growth matrices
We have found that certain forms and composition of fibers and certain high porosity membranes provide highly effective supports for culturing cells and particularly anchorage dependent cells; particularly when said fibers are arranged in flat, highly porous, non-woven sheets, or mats, having an appearance like filter or tissue paper, or of thin porous felt. Said non-woven sheets can be made by any of the wide variety of well known techniques for making non-woven fabrics, papers, or felts, which include spin-bonding, thermal bonding, calendering, needling, etc., techniques. The sheets should preferably be free of glue or adhesive coatings not specifically used to promote cell adhesion to the fiber surfaces.
The fibers used to form the non-woven fiber sheets may be in the form of continuous filaments, staple filaments, hollow filaments, pulp, or floc, or combinations of such forms, and are preferably disposed in the sheet in a highly disordered, random-like, intertangled, manner; the axes of the fibers forming an open, multi-dimensional array. The porosity of the sheet should range from 40 to 95% with a preferred porosity of 60-80%. Preferred pore-size is between 10 and about 100 pom.
The individual fibers should have deniers (weight in grams of 9000 meters of fiber) of between 0.05 and 5 denier per filament (dpf) with a preferred weight of 1.0 to 1.5 dpf. Fiber cross-section may be round or not, with a preferred cross-section being that of a ribbon, that may in addition have a crimp imposed along its axis. Fiber width may range from 0.5 to 50 micrometers, but a preferred width is 10 to 15 micrometers. When hollow filaments are incorporated in the non-woven sheet, they may have single or multiple lumens and their denier will generally be greater than solid cross-section fiber, ranging as high as 50 denier per filament.
High porosity membranes suitable for this application must have a sponge-like structure and porosity, and pore dimensions similar to the non-woven fiber mats; that is 40 to 95% porosity and pore size between 10 and 80 micrometers. Pores must be opened and have high tortuosity. The polymer matrix should be continuous and can have any composition that promotes cell adhesion. Examples of polymers suitable for porous membrane growth are cellulose, cellulose acetate, polyethylene, polyesters, polyfluorochloroethylenes, polyvinylchlorides, polystyrenes, polysulfones, fiber glass, etc.
The thickness of the non-woven fiber sheet or porous membrane is an important parameter. Under proper culture conditions many cells inoculated on these sheets grow within the thickness of the sheet, rather than on the top surfaces of the sheet. Cells proliferate among the fibers of the sheet in three dimensions, rather than in two dimensions as in conventional tissue culture bottles, flasks, petri dishes and on microcarrier beads. Cells may attach themselves to more than one fiber (Figure 1) and cell growth thus takes place in the internal volume of the fiber matrix. The cells form a multilayered tissue-like structure whose thickness is that of the non-woven fiber sheet.To ensure adequate diffusion of nutirents and products to and from the interior of the cell aggregate and to prevent necrosis of cells in the interior of this dense structure, the sheet must be between about 25 and 250 vim thick. A preferred thickness is 100-150 pm. An ideal sheet thickness is approximately equal to the spacing of capillaries that occurs in vivo in the particular kind of tissue being cultured.
The non-woven porous growth matrix sheets may be used alone or they can be thermally bonded to rigid support materials that help the sheets retain their shape, or prevent the sheets from settling into dense contact with each other when used in a close packed array. A particularly useful configuration is to thermally laminate the growth matrix sheet to coarse (1 mm mesh) polypropylene screen (Figure 2). This also allows adjustment of the net density of the matrix so that it can be neutrally buoyant when used in a suspension culture.
The growth matrix sheets and the support and separator sheets may be provided with means to distribute liquid medium uniformly to all parts of a stack of such sheets and with means to promote the flow of medium parallel to the plane of each matrix sheet. Such means may be integral baffles or channelling orifices as shown by 20, and 21, in Figure 4a.
Growth matrix sheets can be used in many ways:
- as liners on bottoms of petri dishes or on the inside surfaces of roller bottles, increasing growth surface area by more than one order of magnitude;
- as spiral sheets inside roller bottles (Figure 3);
- as in Figures 6 and 7, as sheets (11) laminated or layered external to and between flattened tubes (13) of permeable or microporous polymers wherein each alternate flattened tube serves as a conduit, the one for liquid nutrient medium (14), the other for gases (15) such as oxygen, air, CO2 and water vapor, the entire assembly being wound into a spiral as shown in Figure 6, or placed in a laminated interleaved stack (Figure 8) and immersed in a closed sterile container (16) Figure 7, filled with nutrient medium (17) and inoculated with cells for cultivation.Gases and nutrient medium are pumped through the flattened permeable tubes in a pulsatile fashion so that cells growing on the porous or non-woven fiber matrix sheet (11) are bathed in gently surging fluid that is never depleted of oxygen or nutrients and in which wastes do not accumulate through stagnation.
Four connections (Figures 6, 7, (18), generally running through the cover (19) of the assembly serve to introduce and remove gases, and nutrient medium to and from the flattened tubes (13). Probes for monitoring culture parameters such as PO2 (10), pH (11) and glucose concentration (12) may be placed in the growth medium (17) external to the flattened spiral tubes and used to control the nutrient (14) flow rate and composition, as well as the gas (15) CO2 and oxygen content. Polypropylene screens or similar spacers (12) are placed inside each flatted tube and between tubes to maintain minimum separation distances between each layer of the spiral or stack.Access to the cell growth matrix (11) and external or immersion growth medium (17) is made through ports (20) that may also be used to perfuse or remove the immersion medium, or for product collection, or for change of medium, or to samples cells.
- as packing in columns that are continuously perfused with medium, (Figure 4);
- as microcarriers in suspension cultures replacing such materials as modified dextran beads. (Reference "Microcarrier Cell Culture" Pharmacia Chemicals, Uppsala, Sweden (1981)).
When used as microcarriers or as column packing the growth matrix is advantageously laminated to polyproplyene screen (as previously mentioned (Figure 2) that are then cut into small discs, squares, rings cruciforms, or corrugated and folded shapes, to give desired hydrodynamic characteristics to the packing or suspension material.
Alternatively the growth matrix material when used as microcarriers in suspension culture can be cut from fibrous non-woven sheets composed of mixtures of fibers whose density and relative proportions give the sheet a near neutral buoyancy. As an example, circular microdiscs having a diameter of 2 millimeters were stamped from a non-woven sheet composed of a ramdomly oriented mixture of 20 weight percent polyethylene terephthalate fibers and 80% fibers of polypropyline. Because the polyethylene terephthalate fibers had a specific gravity of 1.33 and the polypropylene fibers a specific gravity of 0.92, the composite non-woven fabric had a density of 1.002, so that microdiscs stamped from this sheet were kept suspended in liquid medium when stirred at much lower speeds then are required to maintain in suspension discs composed of solid polyethylene terephthalate fibers only.
Near neutral buoyancy microdiscs were also made by combining in suitable proportions hollow filament polymer fibers having gas filled lumens, with solid, low denier per filament polymer fibers (Figures 2a, 2b). The advantage of microcarriers bearing entrapped gas bubbles is that their buoyancy can be controlled. Because the volume of the entrapped gas increases or decreases as the external pressure on the suspension culture is decreased or increased, the microdiscs are made periodically to float and sink in the nutrient liquid without using an agitator or stirrer. This produces a very gentle washing action and is particularly effective for bringing nutrients to the surface of growing cells and removing metabolic wastes, with cell types that tend to become dislodged from attachment surfaces when stirred.It also eliminates the need for agitators and stirrers, simplifying and reducing the cost of large culture vessels.
A major advantage of this invention is the application of porous matrix cell attachment surfaces to microcarrier tissue cell "suspension culture" (Microcarrier suspension tissue cell culture procedures are described in "Microcarrier Cell Culture," Pharmacia Fine Chemicals, Uppsala, Sweden, (1981); and in the article "Large Scale
Production of Tissue Cells" Scientific American Jan (1983)). For suspension culture application the porous sheet is cut into small pieces, each having a projected surface of between about 1 to 100 square millimeters, with a preferred projected area of about one to 20 square millimeters. The shape of said small pieces may take many forms, with a disc or circular form being preferred.The porous matrix cell attachment sheet material may be thermally bonded to materials such as polypropylene screening having a 1 mm or finer mesh, in order to strengthen the porous matrix material and also in order to increase its buoyancy as described previously. It is particularly advantageous to punch such discs using a heated die so that the fibers at the circumferential edge of the dsic are thermally bonded or partially fused to each other.
We have discovered on theorectical grounds and verified through experiments that such porous matrix microcarriers require substantially lower concentrations of inoculum (cells introduced at the start of a culture) to initiate successful cell growth. For example in a typical suspension culture of microcarriers (modified dextran beads), the inoculum contains 30% of the number of cells that are harvested at the end of the culture
(Fleiscschaker, p. 117, Ph.D. Thesis, June 1982, M.I.T. Dept. of Nutrition and Food Science). We have discovered that when polyester fiber porous matrix microcarriers having a total attachment surface area equal to that of the modified dextran microbeads are used, the inoculum cell content need only be less than about 5% of the final number of cells harvested. This reduction in inoculum size is an immense advantage in large scale
production of tissue cells and cell products, in that production from a single culture can be increased by a factor of approximately 6 to 10, and contamination and reseeding problems are diminished.
The effectiveness of fiber or porous matrix microcarriers with low concentrations of cell inocula is not obvious, and is an important discovery. The explanation for this superior effectiveness is as follows:
In a microcarrier suspension culture, for confluent cell growth to occur on an individual microcarrier particle, a minimum number of inoculum cells must collide with and fix themselves to that microcarrier particle. This minimum number of cells will depend to some extent on the cell type, however a typical number is 7 cells per microcarrier particle. (Fleiscschaker, J., pg 171, Ph.D Thesis June 1982, M.I.T. Dept., of Nutrition (Food
Sceince).Because the collisions between microcarrier particles and inoculum cells are purely random processes, the fraction of microcarrier particles (fj) experiencing collisions with any number (i) of cells can be estimated by the Poisson Distribution (Equation I): fj = A(ei (i) ) (I) where i r the number of inoculant cells colliding with a microcarrier particle r average number of inoculum per microcarrier particle, or, inoculum cells per milliliter/microcarrier
particles per milliliter
If "n" collisions are required to initiate confluent growth, it follows that the fraction (P), of microcarriers experiencing confluent growth will be one minus the fraction of microcarriers having fewer than n collisions.
P= 1 En-1 (f) (II)
when n = 7, and 105 cells/ml are inoculated on a normal concentration of 3 x 104 microcarrier bead particles per milliliter, 15 then 2, in equation I, is equal to 3.3 cells/microcarrier particle. From equation (I), the fractions of particles experiencing zero to six collisions are found to be: f,=.O; f, =.12; f,=.20; f, = .22; f,=.18; f,=.12; f,= 0.7; consequently equation (II) becomes: P=1-(f0+f1+f2+f3+f4+f5+f6) = 0.05 meaning that only one particle in 20 will have 7 or more collisions, and experience confluent cell growth. This culture will therefore fail. Such is in fact the general experience when attempting to inoculate conventional microcarrier cultures at these dilute cell concentrations and conditions (Fleiscschaker ibid. pg. 117).
This statistical reasoning explains the striking superiority of porous or fiber matrix microcarriers. Typically such carriers are 2.0 mm diameter microdiscs stamped from a 150 urn thick non-woven sheet composed of 10 urn diameter polyester fibers. The sheet presents an area for cell attachment of more than 3000 cm2/gram of sheet material. A concentration of 50 such microdiscs per milliliter of culture solution furnishes the same cell attachment area as 3 x 104 conventional microcarrier beads per milliliter. At 105 cells/ml inoculant concentration the average number of inoculant cells per microdisc, (2), is now 105/50, or 2000 cells/per microdisc (in contrast to 3.3 cells per microbead).
The collision frequency of a microdisc with these 2000 cells is magnitudes higher than that of a dextran microcarrier bead with its 3.3 cells. In fact insertion of 2 = 2000 in equation (I) shows that disc particles having fewer than even 100 cell collisions are vanishingly rare. Consequently at the same inoculant concentration and surface anchorage area, the probability of a microdisc experiencing more than 100 cell collisions is given by equation II as P is approximately equal to one. Therefore all the microdisc carriers are bombarded with cells and their growth surface reaches saturation on exposure to dilute inocula. Experimentally, 1% inoculation has succeeded in producing confluent growth.
This effect cannot be reproduced with microbeads or non-porous carriers because reducing the number of microbeads reduces the surface available for cell attachment hence microbead suspension culture is limited to a heavy inoculum.
Examples 1. Material to be used for cells culture matrices were first passed through a discharge from a plasma torch and
washed with methanol. The materials were sterilized under a UV light then immersed in a solution of 100 lig/ml poly-D-lysine, and rinsed with sterile water. Cell culture was carried out at 37"C, in an atmosphere of
5% CO2 in air.
2. Unwoven sheets of polyester (0.15 mm nominal thickness, 15 urn fibers) or polypropylene (0.15 mm nominal
thickness, 12 urn fibers) were cut into 30 mm diameter circles, and laid on the bottom of 30 mm petri dishes.
The same size tissue culture dishes were used as controls. Human dipolid fibroblasts (lung) (1.5 x 105 cells)
were seeded in each plate with 2.5 ml of DMEM (Dulbeco modified Eagle's medium) + 10% serum and the
progress of the cultures was examined microscopically. It was observed (Figure 1) that the cells formed a
multi-layered, tissue like structure. The culture was continued until the cells appeared as a congruent mass,
whereupon the number of cells in each plate was determined by measuring the amount of DNA. The results
(Table 1) show that 7-10 times more cells were obtained in the polymer matrix than on an equal projected
area of a regular culture dish.
TABLE I
Matrix No. cells/Cm 2 Level of confluency
as observed by microscope
Polypropylene 4 x 105 70%
Polyester 6 x 105 60%
Nunc TC. dish 4 x 104 100%
Sheets of non-woven fabric were cut into 21 x 34 cm rectangles, which were attached as 'lines' to the inside of
850 cm2 corning roller bottles. Uncoated roller bottles were used as controls. The fabric lined bottles were
each seeded with 1) 0.3 x 107, 2)1 x 107 and 3)1.5 x 107 cells. The uncoated bottles were seeded with
1.5 x 107 cells each. All bottles were then half-filled with medium, and cultures were carried out on a rotating
Belleo Roller apparatus 0.5/rev/min. Medium was replaced with fresh medium at 2 day intervals.The
uncoated bottle reached confluence, as judged by microscopic examination after 3 days and contained a cell
count of 5.7 x 107 cells. The 'lined' bottles were cultured for an additional 5 days. DNA determinations
showed that 3-5 x 108 cells were obtained in each fabric lined bottle, irrespective of the amount seeded.
4. Sheets 200 cm long and 21 cm wide of non-woven fabric were laminated to a polypropylene screen (1 mm
opening, 0.6 mm thick). The laminate was rolled into a spiral and placed within a roller bottle against the inner
surface to form a spiral lining 7 layers deep. The roller bottles were seeded each with 1.5 x 107 cells, and half
filled with medium. The progress of culture was followed by removing periodically a piece of the liner, and the
growth medium was replaced periodically (based on analysis of glucose and lactic acid) to avoid nutrient
exhaustion. The cell proliferated with an average doubling time of 1.2 days and reached after 12 days
approximately 4 x 109 cells per bottle.
5. Cell culture on non-woven fabrics in a flow-through reactor were tested in a laboratory scale assembly
depicted in Figure 5. Polypropylene or polyester support matrix was introduced into the reactor chamber
(Figure 5) in wither of the following forms. i) Stacked circles of a laminate of the unwoven fabric and
polypropylene screens. Round holes, 3 mm diameter, were punched (1 or 5 holes per circle) in each circle to
allow medium flow (Figure 4). ii) A rectangle of laminate was rolled into a tight spiral which fitted snugly into
the reactor chamber (Figure 4).
The cells were seeded into the reactor with enough growth medium to cover the matrix. The reactor was
closed and the reservoir was filled with medium. After 4 hours of static incubation, medium circulation was
started. Pump speed was adjusted to give an initial medium residence time of 25 mins, and as the cells
proliferated pumping rate was increased to decrease residence time to about 1 min. The reactor chamber was
sampled periodically, by taking out a piece of support, and determining DNA. After 8 days of culture the cell
density in the reactor chamber reached 2 x 106 cells/ml with stacked circles and nearly 7 x 106 cells/ml with
the spiral.
6. Flocks of fibers of rayon (18 urn thick, 0.5 - 2 mm long), nylon (15 urn 0.5 - 1.5 mm) and acrylic (10 - 20u x
0.2 -1 mm) were treated as in Example 1. One tenth g. of each was layered on the bottem of 50 mm petri
dishes, seeded with cells and covered with 3 ml of DMEM + 10% serum. The number of cells that attached to
the fiber layer was determined after 24 hours. The attachment efficiency was 15-20% on the acrylic fibers, 35%
on the rayon, and nearly 60% on the nylon fibers. A control with a regular tissue culture dish gave 70%
attachment efficiency.
7. Sheets of non-woven fabric (400 cm2) were cut into small squares (approximately 3 x 3 mm) and loaded
into Techne 200 ml culture vessel with 100 ml of medium. Bottles were seeded with 1 x 106, 5 X 106 and 1.5 X 107 cells each. Stirring was 30 rpm, and for the first 4 hours the stirrer was on for 30 min and off for 5 min.
After that stirring was continuous. On the third day after seeding 70 ml of medium were replaced with fresh
medium and thereafter 35 ml were replaced daily. Cell counts were carried our daily by DNA determination.
Cell attachment determined 24 hours after seeding was on the average 67% (56-81%) independent of
seeding density. The runs were continued for 4 days after seeding and cell doubling time was on the average
about 32 hours. Final cell counts indicated that the cells in each bottle had increased approximately 10 times,
and that the rate of increase was insensitive to low concentration of inoculum.
8. Two millimeter diameter microdiscs were punched from a non-woven fiber sheet composed of 1.5 devices per
filament polyester fibers and 15 devices per filament hollow polypropylene fibers, using a heated die that
thermally bonded the edges of the discs in the manner shown in Figure 2a giving the disc a doubly convex or
lens-like appearance. The discs were then treated as in Example 1, and placed into Techne 200 ml stirred
culture bottles at a concentration of 50 particles per ml in 100 ml of medium. IMR-90 human lung fibroblast
cells were inoculated at a concentration of 105 cells/ml.
Stirring was intermittent and then continuous as in Example 7. Medium was replaced as in Example 7. After 8
days, cells were counted and were found to have a concentration of 4 x 106 cells per milliliter, proving that an
inoculation of 2.5% of final concentration was feasible.
9. A spiral laminated structure comprised of two flattened, one-inch-wide, cellulose dialysis tubes (13); to strips
of surface treated non-woven polyester fabric (11) (1 Oum fiber diameter); and four strips of polypropylene
spacer screening (12) (0.6 um diameter monofilament, 1 mm opening) was assembled in the form shown in
Figure 6 where, each flattened tube (13) had within itself a strip of spacer screening (12), and was bound on
its external flat surfaces by a strip of non-woven fiber-grwoth matrix (11) and spacer screen (12). The entire
assembly was placed in a sterile container (16) and imersed in growth medium (17) as shown in Figure 7.
The dialyses tubes were each 50 cm long. Nutritional medium without serum was pumped through one
flattened tube at a linear flow rate of about 1 cm per second. A sterile mixture of air and 5% CO2 was pumped
through the other flattened permeable spiral tube. By suitable means the discharge flow from the gas tube was
restricted at two minute intervals so as to cause the spiral tube carrying the gas to periodically swell and
contract so as to cause a gentle, reversible, periodic displacement of the growth medium in which the spiral is
immersed.
The laminated spiral assembly of fiber growth matrix, spacers, and tube, was immersed in 100 ml of DMEM
growth medium containing 10% serum. Hybridomas were inoculated into the serum containing growth medium at a density of 1.5 x 105 cells/ml. After nine days the cell concentration in the immersion medium had grown to above 107 cells/ml. The circulating medium contained no serum. The immersion growth medium contained serum and was perfused at a rate that replaced the serum once every 24 hours. After nine days, when full growth had been attained the immersion growth medium was changed to a production immersion medium that contained no serum. The perfusion rate was continued with removal of mono-clonal antibody from the immersion medium. The concentration of monoclonal antibody remained stable for 6 weeks at which time the experiment was stopped, although it could have continued.
The spiral assembly separated the growth medium, nutrient medium and gas channels, allowing each to be perfused separately which mass-transfer diffusive contact was maintained among the channels. Serum was conserved and antibody titer was maintained at an optimal level.
LEGENDS TO THE FIGURES
Figures 1 A & B Fibroblasts grown on polyester sheets.
Discs of polyester sheets were cut to fit into 30 mm petri dish. Cells were seeded and allowed to
proliferate for (A) 4 days (B) 12 days. The cells were then fixed and stained with gimza stain for
microscopic obervation.
Figure 2 Matrix sheet (1) laminated to polypropylene screen (2).
Figure 2A Doubly convex suspension culture fibrous microdisc comprised of randomly oriented filaments
of variety of polymers some of which are capable of thermal bonding, and some of which are
hollow and open ended entrapping air or gas bubbles whose size and buoyancy is determined by
external pressure in the suspension culture vessel. The thermally bonded edge-formed by stmping through a heated die or punch.
Figure 2B Hollow fiber showing gas bubbles trapped in lumen.
Figure 3 Spiral sheets of matrix inside roller bottle.
Matrix sheets (1), Polyproylene screen (2)
Figure 4 Matrix sheets as packing in column.
A-circular -B. Spiral. Matrix sheets (1), Polypropylene screen (2).
Figure 5 Laboratory scale reactor with medium perfusion.
Figure 6 Spiral assembly of growth matrix and flatten ed permeable tubes carrying nutrient medium and
air. Cell growth occurs in the matrix laminated ourside the flattened tubes.
Figure 7 Laminated spiral assembly as in Figure 6, shown inserted in sterile contained containing
immersion growth medium, said container having suitable connections for perfusing all fluid
channels.
Figure 7a Cross-section of laminated spiral assembly of Figure 6 and 7.
Figure 8 Laminated stack of growth matrix sheets interleaved with flattened medium and gas tubes, and
separator screens.
Claims (32)
1. A matrix for use in cell cultivation in vitro providing a high-surface-area substrate, the effective surface of which is from 10 to about 100 times the area of same projected onto a plane surface, comprising a physiologically acceptable network of fibers having a porosity of from 40 to about 95% and a pores size of the order of 10 u to 100 p, or an open-pore foamed structure with a pore size of from about 10 u to 100 p, the overall height of the matrix being of the order of from 50 u to about 500 p.
2. A matrix according to claim 1, having a 3-dimensional structure which is a non-woven fabric from round, flat, non-round, or hollow fibers or combination of such fibers of the order of from 0.5 urn to 50 urn diameter or width.
3. A matrix according to claim 2, wherein the structure is composed of ribbon formed fibers of 2 urn to 20 urn width which may be crimped, and where the ratio of width to thickness is 2:1 or more.
4. A matrix according to claim 1, having an open-pore foamed polymer structure with pores of about 10 u to about 100 p and with a porosity of from 60 to 95%.
5. A matrix according to any of claims 1 to 4, bonded or laminated to a porous support sheet.
6. A matrix according to any of claims 1 to 5, in particle or flake form of from 1 mm2 to about 1 Omm2 projected surface area, and overrall height of 50 urn to about 250 m.
7. A matrix according to any of claims 1 to 6, wherein the surface is modified for increased cell attachment by subjecting same to a corona discharge, to a gaseous cold plasma (at low pressure and at a radio frequency) or where said surface is modified by coating with a suitable substance.
8. A matrix-sheet according to any of claims 1 to 6 wherein the surface of the matrix is modified for enhanced cell attachment by reaction with a chemical coupling agent, a derivating agent, or by antibodies to cell surface antigens.
9. A matrix-sheet according to any of claim 1 to 7, wherein the surface is given a net positive or net negative electric charge.
10. A matrix according to any of claims 1 to 7, where the surface of the components of the matrix is coated with poly-D-lysine.
11. A matrix according to any of claims 1 to 8, wherein the fiber material or foamed material is a polyester, a polyalkylene, PVC, polystyrene, collagen fibers, glass fibers, a natural fiber, or an insert metal.
12. A matrix-sheet according to any of claims 1 to 11 that is pleated, folded or spirally wound.
13. A system for in vitro cell culture comprising sequence of a matrix as claimed in any of claims 1 to 9 of up to about 260 p height, a separator sheet and a further such matrix sheet, etc; there being provided a desired number of matrix sheet and separators one above the other in stack form.
14. A system for in vitro cell culture according to claim 13, inserted into, or attached to, the surface of petri dishes, roller bottles, flasks or other container.
1 5. A system for in vitro suspension cell culture according to claim 13, comprising matrix particles, flakes or discs according to claim 6 suspended in a liquid nutrient medium.
16. A system for in vitro culture according to claims 1 3, comprising a column that contains a bed of loosely packed particles comprised of pieces of matrix-sheet and suitable separators or baffles to promote uniform flow of fluids through said bed.
17. A method of in vitro cell cultivation which comprises cultivating said cells on a matrix defined in any of claims 1 to 12 or 18-24 in a stack system defined in any of claims 13 to 16 or 25-28, means being provided for the supply of nutrient and for the removal of waste products.
18. A matrix according to claim 6 comprising of a combination of fibers of polymers having densities higher and lower than water density respectively, said combination having a buoyancy that is substantially neutral in the liquid nutrient medium in which said matrix is suspended.
19. A matrix according to claim 18, wherein said combination of fibers of polymer consists of polypropylene fibers and polyethylene terephthalate fibers having an effective specific gravity of about 1.001 to 1.04.
20. A matrix according to claim 18 wherein said combination of fibers consists of approximately 50 to 80 weight percent polypropylene fibers and about 20 to 50 weight percent polypropylene fiber.
21. A matrix according to claim 6 composed of a combination of fibers having solid cross-sections and hollow cross-sections said combination having a buoyancy that is substantially neutral in the liquid medium in which said matrix is suspended.
22. A matrix according to claim, 21 wherein all or a portion of the hollow fibers have at least one sealed end or obstructed lumen in which air or gas is entrapped and whose buoyancy in liquid medium is a function of the external pressure applied to said medium in the manner of an "Cartesian diver".
23. A system for in vitro suspension either comprising matrix particles according to claim 22, suspended in a liquid medium, wherein said matrix particles are repeatedly made to float and sink through said liquid medium by repeatedly lowering and raising the external pressure applied to said liquid medium.
24. A matrix according to claim 6 comprised of hollow fibers, where one or more has a filled lumen, having an effective specific gravity of about 1.001 to 1.04.
25. A system for in vitro high density culture or growth of cells that is comprised of layers of matrix sheets as hereinbefore described and within which cells are entrapped or anchored, and between which matrix sheet layers are interleaved flattened permeable or microporous tubular conduits through which nutrient medium is conducted, and other permeable microporous flattened tubular conduits serving as channels for air and other gases, said layered interleaved structures arranged in a stack or spiral that is immersed in nutrient medium contained in a suitable sterile housing for introducing and withdrawing cells and fresh and spent liquids and gases, and provided with means for monitoring temperature, pH, glucose concentration and other paramaters of the culture system, all cell growth occurring in the fluid medium outside the flattened, permeable sided, interlayered, tubular channels and largely on the interleaved layers of hereinbefore described matrix sheets.
26. A system according to claim 25, wherein the flattened, interleaved, tubular conduits are composed of permeable or microporous polymer film such as cellulose, polyester, polysulfone, poly halogenated ethylene and other halocarbons.
27. A system according to claim 25 or 26 wherein the fluid cell growth medium outside the flattened, permeable interleaved conduits is perfused.
28. A system according to claim 26, wherein the fluid, cell-growth medium outside the flattened permeable, interleaved polymer tubes, is agitated gently by the periodic increase and decrease of the volume of fluid within one or more of the flattened tubular conduits.
29. A matrix according to claim 1 substantially as hereinbefore described with reference to any one of the
Examples.
30. A stack system according to claim 13 or 25 substantially as hereinbefore described with reference to any one of the Examples.
31. A method according to claim 17 substantially as hereinbefore described with reference to any one of the
Examples.
32. A matrix or stack system according to any one of claims 1 to 16 or 18 to 28 substantially as hereinbefore described with reference to the accompanying drawings.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL75554A IL75554A (en) | 1985-06-18 | 1985-06-18 | Matrix for cell cultivation in vitro |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB8614799D0 GB8614799D0 (en) | 1986-07-23 |
| GB2178447A true GB2178447A (en) | 1987-02-11 |
| GB2178447B GB2178447B (en) | 1989-12-28 |
Family
ID=11056003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8614799A Expired GB2178447B (en) | 1985-06-18 | 1986-06-18 | A system for cell cultivation in vitro. |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPH0829077B2 (en) |
| GB (1) | GB2178447B (en) |
| IL (1) | IL75554A (en) |
Cited By (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2221920A (en) * | 1988-08-04 | 1990-02-21 | Ion Tech Ltd | Cell culture apparatus |
| EP0263371A3 (en) * | 1986-10-04 | 1990-05-23 | Akzo N.V. | Process and apparatus for animal cell culture |
| US4937196A (en) * | 1989-08-18 | 1990-06-26 | Brunswick Corporation | Membrane bioreactor system |
| WO1990010018A1 (en) * | 1989-02-23 | 1990-09-07 | Creative Biomolecules, Inc. | Bone collagen matrix for implants |
| EP0435871A4 (en) * | 1988-07-05 | 1991-05-14 | Albert J Banes | Floating cell culture device and method. |
| EP0451706A1 (en) * | 1990-04-06 | 1991-10-16 | Sakai Engineering Co., Ltd. | Ultra-lightweight, open-pore foamed cellulose materials with large surface areas, having ion-exchangeable functional groups introduced therein |
| EP0380610A4 (en) * | 1988-05-23 | 1991-12-18 | Regents Of The University Of Minnesota | Bioreactor device |
| EP0462426A1 (en) * | 1990-06-01 | 1991-12-27 | FIDIA S.p.A. | Biocompatible perforated membranes and their use as artificial skin |
| US5108753A (en) * | 1988-04-08 | 1992-04-28 | Creative Biomolecules | Osteogenic devices |
| EP0475303A3 (en) * | 1990-09-07 | 1992-07-01 | The Dow Chemical Company | Growth of cells in hollow fibers in an agitated vessel |
| WO1992018609A1 (en) * | 1991-04-12 | 1992-10-29 | Vito | Membranes with immobilized microorganisms thereon and/or therein, process for obtaining such membranes, reactor comprising said membranes and process involving the use of said membranes, in particular for the elimination of metals or the degradation of xenobiotic organic compounds |
| US5162225A (en) * | 1989-03-17 | 1992-11-10 | The Dow Chemical Company | Growth of cells in hollow fibers in an agitated vessel |
| US5162114A (en) * | 1989-02-23 | 1992-11-10 | Stryker Corporation | Bone collagen matrix for xenogenic implants |
| US5168058A (en) * | 1987-04-03 | 1992-12-01 | Yeda Research And Development Company, Ltd. | Cell culture carriers and method of use |
| WO1993012877A1 (en) * | 1991-12-20 | 1993-07-08 | Allied-Signal Inc. | Low density materials having high surface areas and articles formed therefrom for use in the recovery of metals |
| US5254471A (en) * | 1986-10-06 | 1993-10-19 | Toray Industries, Inc. | Carrier for cell culture |
| US5266683A (en) * | 1988-04-08 | 1993-11-30 | Stryker Corporation | Osteogenic proteins |
| GB2252562B (en) * | 1990-03-05 | 1994-04-20 | Smith & Nephew | Wound dressing comprising cultured cells |
| WO1994012614A1 (en) * | 1992-11-25 | 1994-06-09 | Cultor Ltd. | Bioreactor with immobilized lactic acid bacteria and the use thereof |
| US5354557A (en) * | 1988-04-08 | 1994-10-11 | Stryker Corporation | Osteogenic devices |
| US5476783A (en) * | 1992-03-23 | 1995-12-19 | Koch Engineering Company, Inc. | Bioreactor method of culturing and propagating cells with a woven motionless mixing element |
| US5501971A (en) * | 1993-01-29 | 1996-03-26 | New Brunswick Scientific Co., Inc. | Method and apparatus for anchorage and suspension cell culture |
| US5502082A (en) * | 1991-12-20 | 1996-03-26 | Alliedsignal Inc. | Low density materials having good compression strength and articles formed therefrom |
| US5508174A (en) * | 1993-06-18 | 1996-04-16 | The United States Of America As Represented By The Secretary Of The Air Force | Method and micro roller bottle for in vitro exposure of cells to volatile chemicals |
| US5525710A (en) * | 1991-12-20 | 1996-06-11 | Alliedsignal Inc. | Highly porous chitosan bodies |
| EP0671469A3 (en) * | 1994-03-09 | 1996-12-18 | Japan Res Dev Corp | Support penetrating a cell culture medium, culture method and apparatus using this support. |
| US5605835A (en) * | 1988-05-23 | 1997-02-25 | Regents Of The University Of Minnesota | Bioreactor device with application as a bioartificial liver |
| EP0743979A4 (en) * | 1994-02-04 | 1997-03-12 | Difco Lab | Microbiological culture bottle, and method of making and using same |
| US5645591A (en) * | 1990-05-29 | 1997-07-08 | Stryker Corporation | Synthetic bone matrix |
| US5702945A (en) * | 1995-02-15 | 1997-12-30 | Heraeus Instruments Gmbh | Culture vessel for cell cultures on a carrier |
| US5776747A (en) * | 1994-07-20 | 1998-07-07 | Cytotherapeutics, Inc. | Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer |
| US5786215A (en) * | 1987-05-20 | 1998-07-28 | Baxter International Inc. | Method for culturing animal cells |
| US5843431A (en) * | 1994-07-20 | 1998-12-01 | Cytotherapeutics, Inc. | Controlling proliferation of cells before and after encapsulation in a bioartificial organ by gene transformation |
| US5955353A (en) * | 1997-05-22 | 1999-09-21 | Excorp Medical, Inc. | Hollow fiber bioreactor with an extrafilament flow plug |
| AU714517B2 (en) * | 1995-10-06 | 2000-01-06 | Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Academisch Medisch Centrum | Solid support for use in cell cultivation, especially for the cultivation of liver cells, biological reactor containing said solid support and the use thereof in bio-artificial liver system |
| US6013511A (en) * | 1993-11-05 | 2000-01-11 | Vito | Precipitating metals or degrading xenobiotic organic compounds with membrane immobilized microorganisms |
| US6194198B1 (en) * | 1998-11-24 | 2001-02-27 | Bonno Koers | Device for purifying gases, such as air in particular, or liquids, such as water in particular, and method for use with the device |
| US6495364B2 (en) | 1995-05-23 | 2002-12-17 | Neurotech, S.A. | Mx-1 conditionally immortalized cells |
| US6586388B2 (en) | 1988-04-08 | 2003-07-01 | Stryker Corporation | Method of using recombinant osteogenic protein to repair bone or cartilage defects |
| WO2004067733A1 (en) * | 2003-01-31 | 2004-08-12 | Himedica Limited | Improvements in and relating to cell growth |
| WO2003092982A3 (en) * | 2002-05-04 | 2004-12-09 | Membrana Gmbh | Method for producing foamed polymer moulded bodies and foamed polymer moulded bodies |
| US6919308B2 (en) | 1988-04-08 | 2005-07-19 | Stryker Corporation | Osteogenic devices |
| WO2015155493A1 (en) * | 2014-04-10 | 2015-10-15 | J R Biomedical Limited | Apparatus for the culture of parasites |
| US9896563B2 (en) | 2005-08-10 | 2018-02-20 | Toray Industries, Inc. | Process for producing spongelike structure |
| US12102944B2 (en) | 2008-10-17 | 2024-10-01 | Bioair Solutions Llc | Method of reducing the concentration of hydrogen sulfide in a gas stream |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0746988B2 (en) * | 1986-03-14 | 1995-05-24 | 日東電工株式会社 | Cultivation method and culture device for adherent animal cells |
| JPH01179685A (en) * | 1988-01-07 | 1989-07-17 | Kirin Brewery Co Ltd | Cell culture container and its inner surface treatment method |
| JPH07114686B2 (en) * | 1989-06-26 | 1995-12-13 | 明治乳業株式会社 | Circulating culture device |
| US6245345B1 (en) * | 1998-07-07 | 2001-06-12 | Atrix Laboratories, Inc. | Filamentous porous films and methods for producing the same |
| US8435781B2 (en) | 2004-08-17 | 2013-05-07 | Kyushu Institute Of Technology | Porous sheet-form material for cell culture, and bioreactor and culturing method utilizing same |
| US8334121B2 (en) * | 2006-02-13 | 2012-12-18 | Donaldson Company, Inc. | Method of converting cellulosic biomass to alcohol using web comprising fine fiber and bioactive particulate |
| WO2007125288A1 (en) * | 2006-04-28 | 2007-11-08 | Reinnervate Limited | Substrate for the growth of cultured cells in three dimensions |
| EP2543398B1 (en) | 2010-03-02 | 2019-10-16 | FUJIFILM Corporation | Cell support and bone regeneration material |
| AU2011258295B2 (en) | 2010-05-25 | 2015-01-29 | Cook Biotech Incorporated | Methods, substrates, and systems useful for cell seeding of medical grafts |
| JP5868601B2 (en) * | 2011-03-23 | 2016-02-24 | フタムラ化学株式会社 | Scaffolding material for liquid medium |
| TW201546146A (en) | 2014-02-14 | 2015-12-16 | Nissan Chemical Ind Ltd | Active-ester-group-containing composition for producing fibers, and cell culture scaffold material using fibers produced from active-ester-group-containing composition |
| EP3452575A4 (en) * | 2016-05-05 | 2020-03-11 | Terumo BCT, Inc. | AUTOMATED MANUFACTURING AND COLLECTION |
| JP7009957B2 (en) * | 2017-11-28 | 2022-01-26 | 東洋紡株式会社 | Cell culture container and cell culture device |
| SG11202005815UA (en) * | 2017-12-20 | 2020-07-29 | Univercells Tech S A | Bioreactor and related methods |
| EP3906299A4 (en) * | 2019-01-04 | 2022-10-19 | Premas Biotech Private Limited | DEVICE AND METHOD FOR MULTIDIMENSIONAL CELL CULTURE |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1387649A (en) * | 1971-12-07 | 1975-03-19 | Rhone Poulenc Sa | Organosilicon polymer membrane |
| GB1491261A (en) * | 1974-05-17 | 1977-11-09 | Community Blood Council | Cell-containing hollow fibres and use of same for metabolic processes |
| GB1514906A (en) * | 1976-04-12 | 1978-06-21 | Monsanto Co | Cell culture reactor and method |
| GB2062006A (en) * | 1979-09-18 | 1981-05-20 | Asahi Chemical Ind | Cultivating floating animal cells |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62502936A (en) * | 1985-04-04 | 1987-11-26 | ベラツクス コ−ポレ−シヨン | Microsponges and bioreactors |
-
1985
- 1985-06-18 IL IL75554A patent/IL75554A/en not_active IP Right Cessation
-
1986
- 1986-06-18 JP JP61142455A patent/JPH0829077B2/en not_active Expired - Lifetime
- 1986-06-18 GB GB8614799A patent/GB2178447B/en not_active Expired
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1387649A (en) * | 1971-12-07 | 1975-03-19 | Rhone Poulenc Sa | Organosilicon polymer membrane |
| GB1491261A (en) * | 1974-05-17 | 1977-11-09 | Community Blood Council | Cell-containing hollow fibres and use of same for metabolic processes |
| GB1514906A (en) * | 1976-04-12 | 1978-06-21 | Monsanto Co | Cell culture reactor and method |
| GB2062006A (en) * | 1979-09-18 | 1981-05-20 | Asahi Chemical Ind | Cultivating floating animal cells |
Cited By (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0263371A3 (en) * | 1986-10-04 | 1990-05-23 | Akzo N.V. | Process and apparatus for animal cell culture |
| US5254471A (en) * | 1986-10-06 | 1993-10-19 | Toray Industries, Inc. | Carrier for cell culture |
| US5168058A (en) * | 1987-04-03 | 1992-12-01 | Yeda Research And Development Company, Ltd. | Cell culture carriers and method of use |
| US5786215A (en) * | 1987-05-20 | 1998-07-28 | Baxter International Inc. | Method for culturing animal cells |
| US5354557A (en) * | 1988-04-08 | 1994-10-11 | Stryker Corporation | Osteogenic devices |
| US5468845A (en) * | 1988-04-08 | 1995-11-21 | Stryker Corporation | Antibodies to osteogenic proteins |
| US5958441A (en) * | 1988-04-08 | 1999-09-28 | Stryker Biotech Corporation | Devices comprising chondrogenic protein and methods of inducing endochondral bone formation therewith |
| US6551995B1 (en) | 1988-04-08 | 2003-04-22 | Stryker Corporation | Osteogenic devices |
| US7176284B2 (en) | 1988-04-08 | 2007-02-13 | Stryker Corporation | Osteogenic proteins |
| US5108753A (en) * | 1988-04-08 | 1992-04-28 | Creative Biomolecules | Osteogenic devices |
| US6919308B2 (en) | 1988-04-08 | 2005-07-19 | Stryker Corporation | Osteogenic devices |
| US5266683A (en) * | 1988-04-08 | 1993-11-30 | Stryker Corporation | Osteogenic proteins |
| US5863758A (en) * | 1988-04-08 | 1999-01-26 | Stryker Corporation | Nucleic acids encoding osteogenic proteins |
| US6586388B2 (en) | 1988-04-08 | 2003-07-01 | Stryker Corporation | Method of using recombinant osteogenic protein to repair bone or cartilage defects |
| EP0380610A4 (en) * | 1988-05-23 | 1991-12-18 | Regents Of The University Of Minnesota | Bioreactor device |
| US5605835A (en) * | 1988-05-23 | 1997-02-25 | Regents Of The University Of Minnesota | Bioreactor device with application as a bioartificial liver |
| US5981211A (en) * | 1988-05-23 | 1999-11-09 | Regents Of The University Of Minnesota | Maintaining cells for an extended time by entrapment in a contracted matrix |
| EP0435871A4 (en) * | 1988-07-05 | 1991-05-14 | Albert J Banes | Floating cell culture device and method. |
| GB2221920A (en) * | 1988-08-04 | 1990-02-21 | Ion Tech Ltd | Cell culture apparatus |
| US5162114A (en) * | 1989-02-23 | 1992-11-10 | Stryker Corporation | Bone collagen matrix for xenogenic implants |
| US5171574A (en) * | 1989-02-23 | 1992-12-15 | Stryker Corporation | Bone collagen matrix for implants |
| US4975526A (en) * | 1989-02-23 | 1990-12-04 | Creative Biomolecules, Inc. | Bone collagen matrix for zenogenic implants |
| WO1990010018A1 (en) * | 1989-02-23 | 1990-09-07 | Creative Biomolecules, Inc. | Bone collagen matrix for implants |
| US5162225A (en) * | 1989-03-17 | 1992-11-10 | The Dow Chemical Company | Growth of cells in hollow fibers in an agitated vessel |
| US4937196A (en) * | 1989-08-18 | 1990-06-26 | Brunswick Corporation | Membrane bioreactor system |
| GB2252562B (en) * | 1990-03-05 | 1994-04-20 | Smith & Nephew | Wound dressing comprising cultured cells |
| EP0451706A1 (en) * | 1990-04-06 | 1991-10-16 | Sakai Engineering Co., Ltd. | Ultra-lightweight, open-pore foamed cellulose materials with large surface areas, having ion-exchangeable functional groups introduced therein |
| US6605117B2 (en) | 1990-05-29 | 2003-08-12 | Stryker Corporation | Synthetic bone matrix |
| US6468308B1 (en) | 1990-05-29 | 2002-10-22 | Stryker Corporation | Synthetic bone matrix |
| US5645591A (en) * | 1990-05-29 | 1997-07-08 | Stryker Corporation | Synthetic bone matrix |
| US5650164A (en) * | 1990-06-01 | 1997-07-22 | Fidia S.P.A. | Process for preparing artificial skin with biocompatible perforated membranes |
| US5326356A (en) * | 1990-06-01 | 1994-07-05 | Fidia S.P.A. | Biocompatible perforated membranes, processes for their preparation, their use as a support in the in vitro growth of epithelial cells, the artificial skin obtained in this manner, and its use in skin grafts |
| US5658331A (en) * | 1990-06-01 | 1997-08-19 | Fidia S.P.A. | Biocompatible perforated membranes, processes for their preparation, their use as a support in the in vitro growth of epithelial cells, the artificial skin obtained in this manner, and its use in skin grafts |
| EP0462426A1 (en) * | 1990-06-01 | 1991-12-27 | FIDIA S.p.A. | Biocompatible perforated membranes and their use as artificial skin |
| EP0475303A3 (en) * | 1990-09-07 | 1992-07-01 | The Dow Chemical Company | Growth of cells in hollow fibers in an agitated vessel |
| WO1992018609A1 (en) * | 1991-04-12 | 1992-10-29 | Vito | Membranes with immobilized microorganisms thereon and/or therein, process for obtaining such membranes, reactor comprising said membranes and process involving the use of said membranes, in particular for the elimination of metals or the degradation of xenobiotic organic compounds |
| US5494940A (en) * | 1991-12-20 | 1996-02-27 | Alliedsignal Inc. | Low density materials having high surface areas and articles formed therefrom |
| US5541234A (en) * | 1991-12-20 | 1996-07-30 | Alliedsignal Inc. | Process for making low density hydrogel materials having high surface areas |
| WO1993012877A1 (en) * | 1991-12-20 | 1993-07-08 | Allied-Signal Inc. | Low density materials having high surface areas and articles formed therefrom for use in the recovery of metals |
| US5525710A (en) * | 1991-12-20 | 1996-06-11 | Alliedsignal Inc. | Highly porous chitosan bodies |
| US5502082A (en) * | 1991-12-20 | 1996-03-26 | Alliedsignal Inc. | Low density materials having good compression strength and articles formed therefrom |
| US5565361A (en) * | 1992-03-23 | 1996-10-15 | Koch Engineering Company, Inc. | Bioreactor for culturing and propagating cells with a woven motionless mixing element |
| US5476783A (en) * | 1992-03-23 | 1995-12-19 | Koch Engineering Company, Inc. | Bioreactor method of culturing and propagating cells with a woven motionless mixing element |
| US5635368A (en) * | 1992-11-25 | 1997-06-03 | Cultor Ltd. | Bioreactor with immobilized lactic acid bacteria and the use thereof |
| WO1994012614A1 (en) * | 1992-11-25 | 1994-06-09 | Cultor Ltd. | Bioreactor with immobilized lactic acid bacteria and the use thereof |
| US5501971A (en) * | 1993-01-29 | 1996-03-26 | New Brunswick Scientific Co., Inc. | Method and apparatus for anchorage and suspension cell culture |
| US5508174A (en) * | 1993-06-18 | 1996-04-16 | The United States Of America As Represented By The Secretary Of The Air Force | Method and micro roller bottle for in vitro exposure of cells to volatile chemicals |
| US6013511A (en) * | 1993-11-05 | 2000-01-11 | Vito | Precipitating metals or degrading xenobiotic organic compounds with membrane immobilized microorganisms |
| EP0743979A4 (en) * | 1994-02-04 | 1997-03-12 | Difco Lab | Microbiological culture bottle, and method of making and using same |
| US5736399A (en) * | 1994-03-09 | 1998-04-07 | Research Development Corporation Of Japan | Medium-penetrating cell culture carrier, a culturing method and a device using this carrier |
| EP0671469A3 (en) * | 1994-03-09 | 1996-12-18 | Japan Res Dev Corp | Support penetrating a cell culture medium, culture method and apparatus using this support. |
| US5776747A (en) * | 1994-07-20 | 1998-07-07 | Cytotherapeutics, Inc. | Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer |
| US5843431A (en) * | 1994-07-20 | 1998-12-01 | Cytotherapeutics, Inc. | Controlling proliferation of cells before and after encapsulation in a bioartificial organ by gene transformation |
| US5935849A (en) * | 1994-07-20 | 1999-08-10 | Cytotherapeutics, Inc. | Methods and compositions of growth control for cells encapsulated within bioartificial organs |
| US5795790A (en) * | 1994-07-20 | 1998-08-18 | Cytotherapeutics, Inc. | Method for controlling proliferation and differentiation of cells encapsulated within bioartificial organs |
| US5858747A (en) * | 1994-07-20 | 1999-01-12 | Cytotherapeutics, Inc. | Control of cell growth in a bioartificial organ with extracellular matrix coated microcarriers |
| US5833979A (en) * | 1994-07-20 | 1998-11-10 | Cytotherapeutics, Inc. | Methods and compositions of growth control for cells encapsulated within bioartificial organs |
| US5840576A (en) * | 1994-07-20 | 1998-11-24 | Cytotherapeutics, Inc. | Methods and compositions of growth control for cells encapsulated within bioartificial organs |
| US6392118B1 (en) | 1994-07-20 | 2002-05-21 | Neurotech S.A. | Mx-1 conditionally immortalized cells |
| US5853717A (en) * | 1994-07-20 | 1998-12-29 | Cytotherapeutics, Inc. | Methods and compositions of growth control for cells encapsulated within bioartificial organs |
| US5702945A (en) * | 1995-02-15 | 1997-12-30 | Heraeus Instruments Gmbh | Culture vessel for cell cultures on a carrier |
| US6495364B2 (en) | 1995-05-23 | 2002-12-17 | Neurotech, S.A. | Mx-1 conditionally immortalized cells |
| US6372495B1 (en) * | 1995-10-06 | 2002-04-16 | Seed Capital Investments-2 (Sci-2) B.V. | Bio-artificial organ containing a matrix having hollow fibers for supplying gaseous oxygen |
| AU714517B2 (en) * | 1995-10-06 | 2000-01-06 | Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Academisch Medisch Centrum | Solid support for use in cell cultivation, especially for the cultivation of liver cells, biological reactor containing said solid support and the use thereof in bio-artificial liver system |
| US5955353A (en) * | 1997-05-22 | 1999-09-21 | Excorp Medical, Inc. | Hollow fiber bioreactor with an extrafilament flow plug |
| US6194198B1 (en) * | 1998-11-24 | 2001-02-27 | Bonno Koers | Device for purifying gases, such as air in particular, or liquids, such as water in particular, and method for use with the device |
| WO2003092982A3 (en) * | 2002-05-04 | 2004-12-09 | Membrana Gmbh | Method for producing foamed polymer moulded bodies and foamed polymer moulded bodies |
| US7429420B2 (en) | 2002-05-04 | 2008-09-30 | Membrana Gmbh | Method for producing foamed polymer molded bodies and said foamed polymer molder bodies |
| WO2004067733A1 (en) * | 2003-01-31 | 2004-08-12 | Himedica Limited | Improvements in and relating to cell growth |
| US9896563B2 (en) | 2005-08-10 | 2018-02-20 | Toray Industries, Inc. | Process for producing spongelike structure |
| US12102944B2 (en) | 2008-10-17 | 2024-10-01 | Bioair Solutions Llc | Method of reducing the concentration of hydrogen sulfide in a gas stream |
| WO2015155493A1 (en) * | 2014-04-10 | 2015-10-15 | J R Biomedical Limited | Apparatus for the culture of parasites |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62122586A (en) | 1987-06-03 |
| GB2178447B (en) | 1989-12-28 |
| IL75554A (en) | 1993-01-14 |
| GB8614799D0 (en) | 1986-07-23 |
| JPH0829077B2 (en) | 1996-03-27 |
| IL75554A0 (en) | 1985-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5266476A (en) | Fibrous matrix for in vitro cell cultivation | |
| GB2178447A (en) | A matrix for cell cultivation in vitro | |
| CA2244659C (en) | Biological reactor for the cultivation of cells | |
| US5149649A (en) | Multi-layered porous hollow fiber membrane for use in cell culture | |
| US5786215A (en) | Method for culturing animal cells | |
| JP3246664B2 (en) | Scaffold and method for culturing suspended cells and apparatus therefor | |
| AU777290B2 (en) | Culture chamber | |
| US5376548A (en) | Bioreactor apparatus | |
| US6228607B1 (en) | Bioreactor | |
| EA009716B1 (en) | Cell cultivation method | |
| EP1425379B1 (en) | Method and structure for growing living organic tissue | |
| US20040067585A1 (en) | Cell cultivation surface and method of making the same | |
| EP0123326A2 (en) | Method for cell culture growth | |
| WO2002031108A1 (en) | Cell culture case | |
| JP7619715B2 (en) | Carrier for cell biomass production and cell culture device including same | |
| JP2024501108A (en) | Packed bed bioreactor with controlled area porosity | |
| DE102010005415B4 (en) | Method and device for the dynamic expansion and / or differentiation of suspended primary cells or stem cells of human and animal origin | |
| JP2619885B2 (en) | Cell culture method and device | |
| JP4262695B2 (en) | Membrane biodevice and bioreactor | |
| JP2001178445A (en) | Carrier for culturing three-dimensional animal cell and three-dimensional animal cell | |
| KR102915458B1 (en) | Carrier for cell biomass production and cell culture device comprising the same | |
| US20240287431A1 (en) | Rolled cell culture substrates for fixed bed bioreactors with controlled perfusion zones | |
| JPH0585156B2 (en) | ||
| JP3139794B2 (en) | Hollow fiber membrane cell culture device | |
| JPH0568230B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PE20 | Patent expired after termination of 20 years |
Effective date: 20060617 |